On this basis, Li et al. investigated whether the expression levels of P2Y12 in the medial PFC (mPFC) were associated with the comorbidity associated with visceral pain and depression in IBD, and also whether EA could be used to treat IBD by targeting P2Y12 receptors (Li et al., 2021). This evidence concerns the gene P2RY12 and irritable bowel syndrome.